Cytoplasmic viscosity is a potential biomarker for metastatic breast cancer cells

被引:5
|
作者
Dessard, Marie [1 ,2 ]
Manneville, Jean-Baptiste [1 ]
Berret, Jean-Francois [1 ]
机构
[1] Univ Paris Cite, CNRS, Matiere & Syst Complexes, F-75013 Paris, France
[2] Aix Marseille Univ, INSERM, CIML, CNRS, F-13009 Marseille, France
来源
NANOSCALE ADVANCES | 2024年 / 6卷 / 06期
关键词
INTRACELLULAR MECHANICS; LIVING CELLS; RHEOLOGY; VISCOELASTICITY; TRANSFORMATION; DEFORMABILITY; ORGANIZATION; CARCINOMA; CORRELATE; DYNAMICS;
D O I
10.1039/d4na00003j
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Cellular microrheology has shown that cancer cells with high metastatic potential are softer compared to non-tumorigenic normal cells. These findings rely on measuring the apparent Young's modulus of whole cells using primarily atomic force microscopy. The present study aims to explore whether alternative mechanical parameters have discriminating features with regard to metastatic potential. Magnetic rotational spectroscopy (MRS) is employed in the examination of mammary epithelial cell lines: MCF-7 and MDA-MB-231, representing low and high metastatic potential, along with normal-like MCF-10A cells. MRS utilizes active micron-sized magnetic wires in a rotating magnetic field to measure the viscosity and elastic modulus of the cytoplasm. All three cell lines display viscoelastic behavior, with cytoplasmic viscosities ranging from 10 to 70 Pa s and elastic moduli from 30 to 80 Pa. It is found that the tumorigenic MCF-7 and MDA-MB-231 cells are softer than the MCF-10A cells, with a twofold decrease in the elastic modulus. To differentiate cells with low and high malignancy however, viscosity emerges as the more discriminating parameter, as MCF-7 exhibits a 5 times higher viscosity as compared to MDA-MB-231. These findings highlight the sensitivity of cytoplasmic viscosity to metastatic activity, suggesting its potential use as a mechanical marker for malignant cancer cells. Intracellular microrheology reveals static viscosity, not elastic modulus, as a potential marker for invasive and metastatic cancer cells.
引用
收藏
页码:1727 / 1738
页数:12
相关论文
共 50 条
  • [41] Hypothyroidism as a potential biomarker of efficacy of famitinib, a novel VEGFR-2 inhibitor in metastatic breast cancer
    Jun Cao
    Jian Zhang
    Zhonghua Wang
    Biyun Wang
    Fangfang Lv
    Leiping Wang
    Xichun Hu
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 389 - 398
  • [42] Dedicator of Cytokinesis 4: A Potential Prognostic and Predictive Biomarker Within the Metastatic Spread of Breast Cancer to Bone
    Brown, Janet E.
    Westbrook, Jules A.
    Wood, Steven L.
    CANCER INFORMATICS, 2019, 18
  • [43] Hypothyroidism as a potential biomarker of efficacy of famitinib, a novel VEGFR-2 inhibitor in metastatic breast cancer
    Cao, Jun
    Zhang, Jian
    Wang, Zhonghua
    Wang, Biyun
    Lv, Fangfang
    Wang, Leiping
    Hu, Xichun
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (02) : 389 - 398
  • [44] Circulating tumor DNA and metastatic breast cancer: a biomarker for the future?
    Goncalves, Anthony
    BULLETIN DU CANCER, 2013, 100 (10) : 935 - 936
  • [45] Changes in Biomarker Status in Metastatic Breast Cancer and Their Prognostic Value
    Woo, Ji Won
    Chung, Yul Ri
    Ahn, Soomin
    Kang, Eunyoung
    Kim, Eun-Kyu
    Kim, Se Hyun
    Kim, Jee Hyun
    Kim, In Ah
    Park, So Yeon
    JOURNAL OF BREAST CANCER, 2019, 22 (03) : 439 - 452
  • [46] Circulating Tumor DNA as a Biomarker for ADCs in Metastatic Breast Cancer
    Chang, Hannah
    Anawate, Isabela
    Low, Alyssa
    Huang, Shao-Po
    Maues, Julia
    Hodgdon, Christine
    Chan, Isaac
    CANCER RESEARCH, 2024, 84 (09)
  • [47] Is metastatic potential of breast cancer inherent or acquired?
    Xu, RL
    Jaffer, S
    LABORATORY INVESTIGATION, 2004, 84 (04) : 395 - 396
  • [49] Breast Cancer Stem Cells as a Prognostic Biomarker
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (11)
  • [50] TCFβ drives expression of osteogenic molecules in bone metastatic breast cancer cells:: A potential mechanism for breast cancer osteomimicry
    Ni, M.
    Sterling, J. A.
    Roberts, A.
    Lin, L.
    Mundy, G. R.
    Caldwell, R. L.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S188 - S188